You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昭衍新藥(603127.SH)半年度淨利潤預增97.2%到109.1%
格隆匯 08-09 16:57

格隆匯8月9日丨昭衍新藥(603127.SH)公佈,預計20211-6實現歸屬於上市公司股東的淨利潤約人民幣14922.38萬元到人民幣15824.61萬元之間,與上年同期的財務報表數據相比,將增加約人民幣7355.9萬元到人民幣8258.13萬元,同比增加約97.2%109.1%

預計20211-6歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期的財務報表數據相比,將增加約人民幣6090.59萬元到人民幣6992.83萬元,同比增加約95.0%109.1%

預計20211-6實現歸屬於上市公司股東的淨利潤與上年同期經重述後的財務報表數據相比,將增加約人民幣5900.03萬元到人民幣6802.26萬元,同比增加約65.4%75.4%

預計20211-6月實現歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期經重述後的財務報表數據相比,將增加約人民幣4634.73萬元到人民幣5536.96萬元,同比增加約58.9%70.4%

預計20211-6月實現的收入與上年同期的財務報表數據相比,將增加約人民幣11733.37萬元到人民幣15706.92萬元,同比增加約29.5%39.5%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account